272 related articles for article (PubMed ID: 8605104)
1. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
Clifford SC; Neal DE; Lunec J
Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
[TBL] [Abstract][Full Text] [Related]
2. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.
Clifford SC; Thomas DJ; Neal DE; Lunec J
Br J Cancer; 1994 Apr; 69(4):680-6. PubMed ID: 7908215
[TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
4. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas.
Kubo H; Sumizawa T; Koga K; Nishiyama K; Takebayashi Y; Chuman Y; Furukawa T; Akiyama S; Ohi Y
Int J Cancer; 1996 Dec; 69(6):488-94. PubMed ID: 8980253
[TBL] [Abstract][Full Text] [Related]
5. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
6. Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
Rady M; Mostageer M; Rohde J; Zaghloul A; Knüchel-Clarke R; Saad S; Attia D; Mahran L; Spahn-Langguth H
Oncol Rep; 2017 Jul; 38(1):551-560. PubMed ID: 28586062
[TBL] [Abstract][Full Text] [Related]
7. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
9. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer.
Ota E; Abe Y; Oshika Y; Ozeki Y; Iwasaki M; Inoue H; Yamazaki H; Ueyama Y; Takagi K; Ogata T
Br J Cancer; 1995 Sep; 72(3):550-4. PubMed ID: 7669560
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
[TBL] [Abstract][Full Text] [Related]
11. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
13. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
14. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
16. MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.
Hoffmann AC; Wild P; Leicht C; Bertz S; Danenberg KD; Danenberg PV; Stöhr R; Stöckle M; Lehmann J; Schuler M; Hartmann A
Neoplasia; 2010 Aug; 12(8):628-36. PubMed ID: 20689757
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein (MRP) in haematological malignancies.
Nooter K; Burger H; Stoter G
Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
[TBL] [Abstract][Full Text] [Related]
18. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.
Fillpits M; Suchomel RW; Dekan G; Stiglbauer W; Haider K; Depisch D; Pirker R
Br J Cancer; 1997; 75(2):208-12. PubMed ID: 9010028
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
[TBL] [Abstract][Full Text] [Related]
20. [Expression of lung resistance-related protein gene in transitional cell carcinoma of the bladder].
Kong CZ; Zhu YY; Ma ZY; Liu DH; Zeng Y; Li ZL
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):118-21. PubMed ID: 15771821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
